Scinai Immunotherapeutics (2F50) Q4 2021 Earnings Report
0 Followers
DE:2F50 Q4 2021 EPS Results
- Actual EPS
- EUR 0.89
- Consensus EPS
- -EUR 7.55
- Beat/Miss
- Beat by +EUR 8.44
- One Year Ago EPS
- -EUR 32.59
DE:2F50 Q4 2021 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/28/2022
- Time
- Before Open
- Conference Call
- Monday, March 28, 2022
DE:2F50 Upcoming Earnings
Scinai Immunotherapeutics's next earnings date is estimated for December 2, 2026, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2F50 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Dec 02, 2026 | 2026 (Q3) | ―- | -42.14 | ― | ― |
| Aug 20, 2026 | 2026 (Q2) | ―-3.25 | -15.61 | 79.16% (+12.36) | |
| Jun 10, 2026 | 2026 (Q1) | ―0.00 | -7.07 | 100.00% (+7.07) | |
| Apr 01, 2026 | 2025 (Q4) | ―8.51 | -7.07 | 220.31% (+15.58) | |
| Dec 02, 2025 | 2025 (Q3) | ―-42.14 | 0.02 | -225919.05% (-42.16) | |
| Sep 02, 2025 | 2025 (Q2) | ―-15.61 | -0.02 | -87750.00% (-15.59) | |
| May 30, 2025 | 2025 (Q1) | ―-1.06 | -0.01 | -11840.00% (-1.05) | |
| May 07, 2025 | 2024 (Q4) | ―-7.07 | -0.01 | -79480.00% (-7.06) | |
| Nov 22, 2024 | 2024 (Q3) | ―0.02 | 0.18 | -89.50% (-0.16) | |
| Aug 15, 2024 | 2024 (Q2) | ―- | -0.03 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
